Advances In Urology

SCIE

国际简称：ADV UROL 参考译名：泌尿外科的进展

主要研究方向：UROLOGY & NEPHROLOGY 非预警期刊审稿周期：15 Weeks

《泌尿外科的进展》(Advances In Urology)是一本由Hindawi Limited出版的以UROLOGY & NEPHROLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q4 JCR分区
10 年发文量
0.6 IF影响因子
未开放 是否OA
1 issue/year 出版周期
English 出版语言

Advances in Urology is a peer-reviewed open access journal focused on the field of urology, covering a wide range of research topics in urology, including but not limited to the diagnosis, treatment, prevention, and related basic scientific research of urinary system diseases. The journal aims to provide a platform for urologists and researchers worldwide to publish the latest research and perspectives.

Its readership mainly includes urologists, surgeons, resident urologists, researchers, medical students, and healthcare professionals interested in the diagnosis, treatment, and prevention of urinary system diseases. As the journal covers a wide range of content from basic scientific research to clinical practice, it also attracts clinical doctors and researchers who wish to stay informed about the latest research advances and treatment methods. In addition, the open access nature of the journal enables its research findings to be accessed and utilized by a wide readership of medical professionals and the scientific community worldwide. This journal has certain academic importance in the field of urology and is an important publishing channel for urological researchers. It not only promotes the dissemination of the latest research results, but also helps to drive scientific progress in related fields.

[ 查看全部 ]

投稿咨询加急咨询

Advances In Urology期刊信息

ISSN：1687-6369
出版语言：English
是否OA：未开放
E-ISSN：1687-6377
出版地区：United Kingdom
是否预警：否
出版商：Hindawi Limited
出版周期：1 issue/year
开源占比：0.975
Gold OA文章占比：100.00%
OA被引用占比：1
出版国人文章占比：0.02
出版撤稿占比：
研究类文章占比：90.00%

Advances In Urology CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

3.2

0.29

0.759

学科类别	分区	排名	百分位
大类：Medicine 小类：Obstetrics and Gynecology	Q2	97 / 218	55%
大类：Medicine 小类：Urology	Q2	56 / 123	54%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Advances In Urology中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	UROLOGY & NEPHROLOGY 泌尿学与肾脏学	2区

Advances In Urology JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：UROLOGY & NEPHROLOGY	ESCI	Q4	120 / 134	10.8
学科：UROLOGY & NEPHROLOGY	ESCI	Q3	83 / 134	38.43

Advances In Urology历年数据统计

影响因子

中科院分区

Advances In Urology中国学者发文选摘

1、Machine Learning Models and Risk Scoring System for Survival in Bladder Cancer Patients With Type 2 Diabetes: A 20-Year Territory-Wide Cohort Stud
Author: Zhong, Claire Chenwen; Huang, Junjie; Li, Zhaojun; Jiang, Yu; Yang, Zehuan; Yuan, Jinqiu; Huang, Xiaodan; Liu, Xiaofang; Lin, Queran; Wang, Han; Poon, Jonathan; Chi-Fai Ng, Anthony; Wong, Martin C. S

Journal: ADVANCES IN UROLOGY. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/aiu/9956290
2、Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanis
Author: Chen, Chaojiang; Wang, Ranting; Lin, Zhuoyuan; Li, Jianxin; Zheng, Yu

Journal: ADVANCES IN UROLOGY. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/aiu/7448726
3、Prognostic Value of Serum Cystatin C for Predicting Contrast-Induced Nephropathy in Elderly Individuals Aged Over 80 Year
Author: Wang, Xiangxiang; Bian, Zhixiang; Zhu, Rui; Chen, Shunjie

Journal: ADVANCES IN UROLOGY. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/aiu/9478896
4、Transcatheter Arterial Embolization Combined With Systemic Therapy for Metastatic Hormone-Sensitive Prostate Cancer Presenting as a Giant Pelvic Mas
Author: Yan, Zhipeng; Tang, Chunhong; Jiang, Deqi; Zhang, Heng; Xu, Baoqun; Sun, Maokun; Sun, Yi; Sun, Yunji

Journal: ADVANCES IN UROLOGY. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/aiu/6678198
5、Association of Hyperlipidemia on the Prevalence and Risk Factors of Kidney Stones and Hypertensio
Author: Luo, Jie; Chen, Kaizhao; Peng, Lijun; Liu, Peizhong; Chen, Wei; Zhao, Honglei

Journal: ADVANCES IN UROLOGY. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/aiu/5475508
6、Efficacy and Safety of Double-Face Buccal Mucosa Graft Urethroplasty for Obliterative or Near-Obliterative Anterior Urethral Stricture: A Systematic Review and Single-Arm Meta-Analysi
Author: Li, Xingyu; Guo, Qiang; Fan, Lujia; Li, Zhitong; Jin, Mengwei; Li, Chengyong; Wang, Jingqi

Journal: ADVANCES IN UROLOGY. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/aiu/5608421